16th International Conference on Alzheimer’s Drug Discovery

This annual Alzheimer’s Drug Discovery Foundation (ADDF) conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. Participate in this exclusive opportunity to hear presentations by ADDF-funded investigators on the forefront of finding treatments for Alzheimer’s disease and related dementias. The annual conference provides dynamic conversation and stimulating discussion for any professional seeking opportunities to collaborate or partner with similarly dedicated experts. Sessions will focus on: Apolipoproteins and Neuroinflammation; Neuroprotection, Mitochondrial Function and Synaptic Plasticity; Translatable Biomarkers to Accelerate Clinical Development; and Tau, TDP-43, Progranulin and Protein Clearance.

Go here for registration info.